Trump’s drug pricing push sidelines Medicare negotiation program
Inflatie
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound , he’s barely mentioned Medicare’s drug price negotiation program — even though the government is expected to announce lower prices before the end of the month. The program, created under President Joe Biden’s Inflation Reduction Act of 2022 , gave Medicare the authority to negotiate directly with drugmakers on some of the costliest medications. A Centers for Medicare and Medicaid Services (
din zilele anterioare